Applied Therapeutics, Inc.
APLTDelisted Feb 3, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001697532
Applied Therapeutics, Inc. was delisted on Feb 3, 2026; its insiders filed their last Form 4 on Feb 4, 2026; 52 institutions reported holding it in 13F filings for Q4 2025, worth $5.93M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Applied Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Applied Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Kanter Stacy J. | Director | 0 | Feb 4, 2026 | 2 |
| Skyler Jay S | Director | 0 | Feb 3, 2026 | 1 |
| Hooks Corwin Dale | Chief Commercial Officer | 0 | Feb 3, 2026 | 1 |
| Funtleyder Leslie D. | Chief Financial Officer | 0 | Feb 3, 2026 | 3 |
| Lerner Teena | Director | 0 | Feb 3, 2026 | 1 |
| Chinoporos Constantine | See Remarks | 0 | Feb 3, 2026 | 1 |
| Bailey Evan Prescott | Chief Medical Officer | 0 | Feb 3, 2026 | 1 |
| Perfetti Riccardo | Chief Medical Officer | 890,409 | Mar 6, 2025 | 0 |
| Johnson John | Executive Chairman | 500,000 | Dec 20, 2024 | 0 |
| Shendelman Shoshana | President and CEO | 4,690,839 | Aug 14, 2024 | 0 |
| Marcus Joel S | Director | 498,414 | Jun 7, 2024 | 0 |
| Alexandria Real Estate Equities, Inc. | 10% Owner | 5,855,077Indirect | Jun 6, 2024 | 0 |
| Alexandria Venture Investments, LLC | 10% Owner | 5,855,077Indirect | Jun 6, 2024 | 0 |
| Alexandria Equities No. 7, LLC | 10% Owner | 5,855,077Indirect | Jun 6, 2024 | 0 |
| Hansard Adam | Chief Commercial Officer | 732,919 | Mar 18, 2024 | 0 |
| Ortega Steven A. | Principal Accounting Officer | 55,404 | Nov 17, 2022 | 0 |
| Mahadevan Chids | See Remarks | 9,800 | Aug 4, 2022 | 0 |
| Silberstein Charles | Chief Financial Officer | 183,603 | Jan 11, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 18, 2025 (view filing)3:13 PM ET | Dec 16 | 2 days | Kanter Stacy J.Director | SSale | −43.0K | $0.112 | −$4.82K | −39.8%65.0K after | |
| Mar 6, 2025 (view filing)8:30 PM ET | Mar 4 | 2 days | Perfetti RiccardoChief Medical Officer | SSale | −10.4K | $0.44 | −$4.56K | −1.2%890.4K after | |
| Mar 6, 2025 (view filing)8:30 PM ET | Mar 4 | 2 days | Funtleyder Leslie D.See Remarks | SSale | −14.5K | $0.44 | −$6.38K | −3.6%390.5K after | |
| Mar 6, 2025 (view filing)8:30 PM ET | Mar 4 | 2 days | Chinoporos ConstantineSee Remarks | SSale | −447 | $0.44 | −$196.68 | −0.2%271.4K after | |
| Feb 7, 2025 (view filing) | Feb 6 | 1 day | Funtleyder Leslie D.See Remarks | SSale | −22.9K | $0.61 | −$14.0K | −5.4%405.0K after | |
| Feb 7, 2025 (view filing) | Feb 6 | 1 day | Perfetti RiccardoChief Medical Officer | SSale | −86.1K | $0.61 | −$52.5K | −8.7%900.8K after | |
| Feb 7, 2025 (view filing) | Feb 6 | 1 day | Chinoporos ConstantineSee Remarks | SSale | −28.1K | $0.61 | −$17.2K | −9.4%271.9K after | |
| Aug 23, 2024 (view filing) | Aug 22 | 1 day | Funtleyder Leslie D.Chief Financial Officer | SSale | −13.5K | $5.83 | −$78.9K | −4.6%277.9K after | |
| Aug 23, 2024 (view filing) | Aug 22 | 1 day | Perfetti RiccardoChief Medical Officer | SSale | −22.7K | $5.83 | −$132.2K | −2.2%986.9K after | |
| Aug 14, 2024 (view filing) | Aug 12-14 | 2 days | Shendelman ShoshanaPresident and CEO | SSale | −777.0K | $6.06 | −$4.71M | −14.2%4.69M after | 3 lots |
| Jun 10, 2024 (view filing) | Jun 6 | 4 days | Shendelman ShoshanaPresident and CEO | SSale | −61.8K | $4.32 | −$267.0K | −1.6%3.76M after | |
| Jun 10, 2024 (view filing) | Jun 6 | 4 days | Perfetti RiccardoChief Medical Officer | SSale | −22.0K | $4.32 | −$95.1K | −2.1%1.01M after | |
| Jun 10, 2024 (view filing) | Jun 6 | 4 days | Funtleyder Leslie D.Chief Financial Officer | SSale | −17.0K | $4.32 | −$73.4K | −5.5%291.4K after | |
| Jun 6, 2024 (view filing)6:45 PM ET | Jun 4-5 | 2 days | Alexandria Real Estate Equities, Inc. and 2 others10% Owner | SSale | −300.0K | $4.23 | −$1.27M | −4.9%5.86M after | 2 lots |
| Mar 18, 2024 (view filing) | Mar 14 | 4 days | Shendelman ShoshanaPresident and CEO | SSale | −318.6K | $5.39 | −$1.72M | −7.7%3.82M after | |
| Mar 18, 2024 (view filing) | Mar 14 | 4 days | Perfetti RiccardoChief Medical Officer | SSale | −110.8K | $5.39 | −$597.2K | −9.7%1.03M after | |
| Mar 18, 2024 (view filing) | Mar 14 | 4 days | Hansard AdamChief Commercial Officer | SSale | −48.9K | $5.39 | −$263.4K | −6.3%732.9K after | |
| Mar 18, 2024 (view filing) | Mar 14 | 4 days | Funtleyder Leslie D.Chief Financial Officer | SSale | −28.7K | $5.39 | −$154.8K | −8.5%308.4K after | |
| Dec 5, 2023 (view filing) | Dec 1 | 4 days | Kanter Stacy J.Director | PPurchase | +30.0K | $2.18 | +$65.4K | +90.9%63.0K after | |
| Dec 1, 2023 (view filing) | Nov 30 | 1 day | Shendelman ShoshanaPresident and CEO | SSale | −3.97K | $1.97 | −$7.82K | −0.2%2.60M after | |
| Dec 1, 2023 (view filing) | Nov 30 | 1 day | Perfetti RiccardoChief Medical Officer | SSale | −1.58K | $1.97 | −$3.12K | −0.2%692.3K after | |
| Dec 1, 2023 (view filing) | Nov 30 | 1 day | Hansard AdamChief Commercial Officer | SSale | −965 | $1.97 | −$1.90K | −0.3%381.8K after | |
| Nov 6, 2023 (view filing)4:56 PM ET | Nov 2-3 | 4 days | Alexandria Real Estate Equities, Inc. and 2 others10% Owner | SSale | −247.3K | $2.31 | −$572.2K | −4.2%5.58M after | 2 lots |
| Nov 2, 2023 (view filing)4:44 PM ET | Oct 31-Nov 1 | 2 days | Alexandria Real Estate Equities, Inc. and 2 others10% Owner | SSale | −327.7K | $2.38 | −$781.2K | −5.3%5.83M after | 2 lots |
| Sep 29, 2023 (view filing) | Sep 27 | 2 days | Shendelman ShoshanaPresident and CEO | SSale | −115.6K | $2.70 | −$312.2K | −4.3%2.60M after | |
| Sep 29, 2023 (view filing) | Sep 27 | 2 days | Perfetti RiccardoChief Medical Officer | SSale | −10.9K | $2.70 | −$29.5K | −1.6%693.9K after | |
| Sep 29, 2023 (view filing) | Sep 27 | 2 days | Hansard AdamChief Commercial Officer | SSale | −9.72K | $2.70 | −$26.2K | −2.5%382.8K after | |
| Jan 13, 2023 (view filing) | Jan 11 | 2 days | Shendelman ShoshanaPresident and CEO | SSale | −15.9K | $0.91 | −$14.4K | −2.1%751.6K after | |
| Jan 13, 2023 (view filing) | Jan 11 | 2 days | Perfetti RiccardoChief Medical Officer | SSale | −6.05K | $0.91 | −$5.51K | −3.8%154.9K after | |
| Jan 13, 2023 (view filing) | Jan 11 | 2 days | Hansard AdamChief Commercial Officer | SSale | −4.50K | $0.91 | −$4.09K | −4.6%92.5K after | |
| Oct 14, 2022 (view filing) | Oct 14 | Same day | Shendelman ShoshanaPresident and CEO | PPurchase | +50.0K | $0.65 | +$32.5K | +7.0%767.5K after | |
| Oct 13, 2022 (view filing) | Oct 13 | Same day | Shendelman ShoshanaPresident and CEO | PPurchase | +73.3K | $0.56 | +$41.0K | +11.4%717.5K after | |
| Oct 12, 2022 (view filing) | Oct 12 | Same day | Shendelman ShoshanaPresident and CEO | PPurchase | +38.2K | $0.52 | +$19.8K | +6.3%644.2K after | |
| Jun 29, 2022 (view filing)4:37 PM ET | Jun 27 | 2 days | Alexandria Real Estate Equities, Inc. and 2 others10% Owner | PPurchase | +3.50M | $1.00 | +$3.50M | +331.7%4.56M after | 2 lots |
| Jun 29, 2022 (view filing)4:37 PM ET | Jun 27 | 2 days | Alexandria Real Estate Equities, Inc. and 2 others10% Owner | PPurchase | +6.50M | $0.9999 | +$1.50M | –2.95M after | Derivative4 lots |
| May 18, 2022 (view filing) | May 16 | 2 days | Mahadevan ChidsSee Remarks | SSale | −905 | $1.65 | −$1.49K | −8.5%9.80K after | |
| Mar 23, 2022 (view filing) | Mar 21-23 | 2 days | Perfetti RiccardoChief Medical Officer | PPurchase | +64.5K | $1.95 | +$125.8K | +66.9%160.9K after | 3 lots |
| Sep 14, 2021 (view filing) | Sep 13-14 | 1 day | Shendelman ShoshanaPresident and CEO | PPurchase | +10.0K | $14.50 | +$145.1K | +2.8%364.3K after | 2 lots |
| Aug 11, 2021 (view filing) | Aug 9-10 | 2 days | Perfetti RiccardoChief Medical Officer | SSale | −15.8K | $17.34 | −$273.9K | −100.0%0 after | 3 lots |
| Aug 11, 2021 (view filing) | Aug 10 | 1 day | Perfetti RiccardoChief Medical Officer | SSale | +8.27K | $15.85 | +$131.1K | New position600 after | |
| Jul 29, 2021 (view filing) | Jul 27-29 | 2 days | Perfetti RiccardoChief Medical Officer | SSale | −45.0K | $17.30 | −$778.4K | −100.0%0 after | 4 lots |
| Jul 15, 2021 (view filing) | Jul 13-15 | 2 days | Perfetti RiccardoChief Medical Officer | SSale | −1.38K | $20.43 | −$28.2K | −100.0%0 after | 3 lots |